This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks as U.S.

On July 31, the Trump administration called on drug manufacturers to lower prescription drug prices in the U.S. to "most favored nation" – or MFN – pricing, the lowest cost paid for the same ...

Loading the Elevenlabs Text to Speech AudioNative Player... On May 12, President Trump took a big swing at cutting drug prices, issuing an executive order requiring Most Favored Nation (MFN) pricing, ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has weighed heavily on the pharmaceutical industry in recent months, many branded ...

While the most favored nation initiatives have bold aims to lower the cost of drugs, the impact is limited, and in some instances unclear, a case of style over substance.

Germany's drug pricing reforms clash with US MFN policy ambitions. Explore why Europe's largest pharma market holds the key ...

Pharma giants Eli Lily (LLY) and Novo Nordisk (NVO) have signed deals with U.S. President Donald Trump to slash the prices of some of their obesity drugs, including upcoming pills, as per a White ...

He added that the company's plan to sell Foundayo through government channels will depend on the pricing implications of the ...

On May 12, 2025, the White House issued an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” that directed multiple government agencies to take ...

When it comes to global pharma pricing and market access, this moment is one of unprecedented change. As policy initiatives like Most Favoured Nations (MFN) and the EU’s Joint Clinical Assessment ...

What’s new: The U.S. administration’s most-favored-nation (MFN) drug pricing initiative intends to align U.S. drug prices with those in comparable developed nations through executive orders, voluntary ...